Stock Scorecard
Stock Summary for Biomarin Pharmaceutical Inc (BMRN) - $57.50 as of 7/3/2025 8:58:33 PM EST
Total Score
17 out of 30
Safety Score
60 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for BMRN
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for BMRN
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for BMRN
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for BMRN
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for BMRN (60 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for BMRN
Financial Details for BMRN
Company Overview |
|
|---|---|
| Ticker | BMRN |
| Company Name | Biomarin Pharmaceutical Inc |
| Country | USA |
| Description | BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 8/5/2025 |
Stock Price History |
|
| Last Day Price | 57.50 |
| Price 4 Years Ago | 88.35 |
| Last Day Price Updated | 7/3/2025 8:58:33 PM EST |
| Last Day Volume | 1,376,747 |
| Average Daily Volume | 2,322,092 |
| 52-Week High | 94.85 |
| 52-Week Low | 52.93 |
| Last Price to 52 Week Low | 8.63% |
Valuation Measures |
|
| Trailing PE | 21.17 |
| Industry PE | 21.93 |
| Sector PE | 40.90 |
| 5-Year Average PE | 16.22 |
| Free Cash Flow Ratio | 10.51 |
| Industry Free Cash Flow Ratio | 17.71 |
| Sector Free Cash Flow Ratio | 32.91 |
| Current Ratio Most Recent Quarter | 5.52 |
| Total Cash Per Share | 5.47 |
| Book Value Per Share Most Recent Quarter | 30.21 |
| Price to Book Ratio | 1.89 |
| Industry Price to Book Ratio | 34.53 |
| Sector Price to Book Ratio | 30.76 |
| Price to Sales Ratio Twelve Trailing Months | 3.72 |
| Industry Price to Sales Ratio Twelve Trailing Months | 121.97 |
| Sector Price to Sales Ratio Twelve Trailing Months | 35.60 |
| Analyst Buy Ratings | 16 |
| Analyst Strong Buy Ratings | 7 |
Share Statistics |
|
| Total Shares Outstanding | 191,776,000 |
| Market Capitalization | 11,027,120,000 |
| Institutional Ownership | 98.91% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.71% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 108.00% |
| Annual Earnings Growth | 154.62% |
| Reported EPS 12 Trailing Months | 2.70 |
| Reported EPS Past Year | 1.13 |
| Reported EPS Prior Year | 2.49 |
| Net Income Twelve Trailing Months | 523,883,000 |
| Net Income Past Year | 426,859,000 |
| Net Income Prior Year | 167,645,000 |
| Quarterly Revenue Growth YOY | 14.80% |
| 5-Year Revenue Growth | 10.86% |
| Operating Margin Twelve Trailing Months | 30.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 1,048,803,000 |
| Total Cash Past Year | 942,842,000 |
| Total Cash Prior Year | 755,127,000 |
| Net Cash Position Most Recent Quarter | 453,153,000 |
| Net Cash Position Past Year | 347,704,000 |
| Long Term Debt Past Year | 595,138,000 |
| Long Term Debt Prior Year | 593,095,000 |
| Total Debt Most Recent Quarter | 595,650,000 |
| Equity to Debt Ratio Past Year | 0.90 |
| Equity to Debt Ratio Most Recent Quarter | 0.91 |
| Total Stockholder Equity Past Year | 5,657,990,000 |
| Total Stockholder Equity Prior Year | 4,951,549,000 |
| Total Stockholder Equity Most Recent Quarter | 5,793,459,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 620,182,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.23 |
| Free Cash Flow Past Year | 475,423,000 |
| Free Cash Flow Prior Year | 51,648,000 |
Options |
|
| Put/Call Ratio | 0.34 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.18 |
| MACD Signal | -1.20 |
| 20-Day Bollinger Lower Band | 49.56 |
| 20-Day Bollinger Middle Band | 61.86 |
| 20-Day Bollinger Upper Band | 74.15 |
| Beta | 0.18 |
| RSI | 41.30 |
| 50-Day SMA | 68.32 |
| 150-Day SMA | 83.60 |
| 200-Day SMA | 83.38 |
System |
|
| Modified | 7/4/2025 2:34:25 AM EST |